Experience | Support | Patient+ | Weblinks | News | Products | Other
This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Beta Hex Deficiency
Post your experienceSee others (1 there)
Synonyms: Sandhoff disease, Type II GM2 gangliosidosis, hexosaminidase A and B deficiency
The GM2 gangliosidoses are a group of lipid storage diseases caused by a mutation in at least one of three recessive genes: HEXA, HEXB or GM2A. The products of all 3 genes are required for normal catabolism of the GM2 ganglioside substrate. Abnormal catabolism of this substrate results in accumulation of the substrate inside neuronal lysosomes, leading to cell death, most significantly in the brain and spinal cord.
The products of the 3 genes HEXA, HEXB and GM2A are respectively:
- Alpha subunits of b-hexosaminidase A: absence or defects of these results in Tay-Sachs disease (TSD) and its variants.
- Beta subunits of Hex A: absence or defects of these results in Sandhoff disease (SD) and its variants.
- GM2 activator protein.
Different mutations give rise to different clinical phenotypes. TSD is the most common of the GM2 gangliosides. Where there are abnormal beta chains both hexosaminidase A and B will be affected. With combined enzyme deficiency, there is more extensive extraneural involvement.
This record is about the latter group of patients where there is a mutation of the HEXB gene leading to a deficiency of the beta subunit of Hex A and the subunits of Hex B leading to a spectrum of disorders including SD. Patients with these diseases tend to present in with developmental delay and progressive neurodegenerative disorders.
- This is a rare group of disorders affecting approximately 3.22 per million non-Jewish newborns (compared to 1 in a million Jewish newborns - a distinction with TSD where there is an increased prevalence in the Ashkenazi Jewish community).
- Males and females are equally affected.
- Clusters of affected children have occurred in Argentina, Portugal,3 Cyprus (the Maronite community have been highlighted as being at particular risk)1,2 and the Lebanon. In the US, those with an Italian ancestry have been found to be at higher risk of being a carrier for SD.4
- This group of disorders is transmitted as single gene autosomal recessive disorders; consanguinity increases risk.
The syndrome usually presents in infancy (typically at about 6 months old) or early childhood with signs of:
- Developmental delay and neuromuscular problems: floppy baby, dystonia, ataxia, muscle wasting, myoclonus, seizures.
- Ophthalmological problems: cherry red spots seen at the macula, early blindness.
- They may appear to have a 'doll-like' facial appearance
- Extraneural involvement: frequent respiratory infections, mild visceromegaly, occasional foamy histiocytes or vacuolated lymphocytes in peripheral blood.
There are juvenile and adult forms which show delayed onset (between 2 and 10 years old or in adulthood respectively),1 slower progress and longer survival.6
- Other lipid storage diseases such as Tay Sachs disease
- Gaucher disease
- Motor skills disorder
- The mucopolysaccharidoses
- Hurler's syndrome
- Friedreich's ataxia
- Niemann-Pick disease
- Beta-Hex enzyme assay can be undertaken in specialist centres. Hexominidase activity can be measured in serum, leukocytes, tears and cultivated fibroblasts.
- DNA typing will confirm the diagnosis.
- PAS staining of systemic tissues will differentiate Sandhoff disease from the other GM2 gangliosidoses.
- There is currently no specific treatment for patients with these diseases.
- Treatment is supportive (e.g. concentration on nutrition, hydration, airway support) and symptomatic (e.g. anticonvulsants where fitting, treatment of respiratory infections).
Frequent respiratory infections are a common complication .
In general terms, the earlier the presentation, the worse is the prognosis. The prognosis for all forms of Beta-hex deficiency is poor, with most sufferers dying in childhood. Neonates appear normal but increasing motor weakness is usually evident by about 6 months, loss of a swallow reflex will make the child more vulnerable to aspiration and chest infections. Commonly death occurs by about the age of 4.
Genetic counselling - prenatal diagnosis and carrier status can be determined where mutations are known.
Document references
- Kaelbling M; GM2 Gangliosidoses. eMedicine, Sept 2007.
- OMIM; Sandhoff Disease (2007).
- Pinto R, Caseiro C, Lemos M, et al; Prevalence of lysosomal storage diseases in Portugal.; Eur J Hum Genet. 2004 Feb;12(2):87-92. [abstract]
- Branda KJ, Tomczak J, Natowicz MR; Heterozygosity for Tay-Sachs and Sandhoff diseases in non-Jewish Americans with ancestry from Ireland, Great Britain, or Italy.; Genet Test. 2004 Summer;8(2):174-80. [abstract]
- Textbook of Paediatrics, 6th Edition Forfar and Arneil 2003 Churchill Livingstone ISBN 0443071926
- Cashman NR, Antel JP, Hancock LW, et al; N-acetyl-beta-hexosaminidase beta locus defect and juvenile motor neuron disease: a case study.; Ann Neurol. 1986 Jun;19(6):568-72. [abstract]
Internet and further reading
- National Tay Sachs and Associated diseases association
- CLIMB; Children living with inherited metabolic disorders.; Support group involved in fund-raising and research support. Information on metabolic diseases.
DocID: 1289
Document Version: 21
DocRef: bgp1524
Last Updated: 14 Oct 2008
Review Date: 14 Oct 2010
The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest. Find out more about updating.
Patient UK Hearing Impairment Survey
Patient UK are grateful to the 550 people who took part in this survey.
To see the results click here.
If you'd like to leave your feedback, please go to our interactive forum.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicine
View Patient Experience for 'Tay-sachs Disease' (1 there)Support Groups related to this topic (^ top of page)
Tay Sachs and Allied Disease AssociationPatientPlus articles related to this topic (^ top of page)
Tay-Sachs DiseaseLinks to other selected websites related to this topic (^ top of page)
Tay-Sachs DiseasePatient UK Newspaper (^ top of page)
Recent related news items
Care court battle parents speak
Parents fight for 'right to life'All news by related topic
Tay-sachs Disease newsRelated Products (^ top of page)
Medical equipment

Books

Other - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
UK Guidelines
Online Videos
Medline
Other good health sites
Want to search some more? Use the Google Search box below to search our site.
Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.
Want to advertise on this site? Find out how >>
Here you can follow a link to view existing patient experiences on this subject, or to add your own
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Note: this will open in a new window
Note: this will open in a new window
Here you can follow a link to view existing patient experiences on this subject, or to add your own
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Note: this will open in a new window
Note: this will open in a new window




